Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 24
  • Journal CiteScore: 8.01
  • Journal Impact Factor: 7.55
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page


Antimicrobial Behavior of Zinc Oxide Nanoparticles and �?Ž�?²-Lactam Antibiotics against Pathogenic Bacteria

Farzana R, Iqra P, Shafaq F, Sumaira S, Zakia K, Hunaiza T, Husna M

Background: Multi-drug resistance among the pathogenic bacteria poses a serious threat to public health. Nanoparticles are one of the most effective therapeutic agents. Zinc oxide nanoparticles (ZnO NPs) are well known antimicrobial agents and are regarded as nontoxic and bio-safe. The present study aims to investigate the antimicrobial effect of ZnO NPs against the bacterial strains i.e. Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E.coli).

Methodology: The antibacterial activity was performed by Kirby’s Disc diffusion assay using different concentrations (0.2, 0.4, 0.6, 0.8 and 1.0) mg/ml of ZnO NPs with and without β lactam antibiotics (Ciprofloxacin and Imipenem). The Minimum inhibitory concentration (MIC) was evaluated through the standard agar dilution method. Antioxidant potential of ZnO NPs was analyzed through αα-diphenyl-β- picrylhydrazyl (DPPH) radical scavenging activity while the Cytotoxicity of ZnO NPs was evaluated through Brine shrimp lethality assay.

Results: The results revealed that the highest zone of inhibition was more in K. pneumoniae i.e. 27.2 mm as compared to E.coli i.e. 13.2 mm. The MIC value for K. pneumoniae and E.coli was 0.05 mg/ml and 0.08 mg/ml respectively. Antioxidant potential of ZnO NPs increases as the concentration of NPs was increased. However, the cytotoxicity analysis showed the non-toxic effect of ZnO NPs.

Conclusion: The results indicated that ZnO NPs possess strong antimicrobial activity and can enhance the antimicrobial activity of some beta-lactam antibiotics. The present study can be helpful to formulate nano-drug conjugates as antimicrobial agents in various fields of medical and pharmaceutical research.